BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 26841863)

  • 1. Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveals a Mechanism for Regulation of Tumor Progression.
    Coke CJ; Scarlett KA; Chetram MA; Jones KJ; Sandifer BJ; Davis AS; Marcus AI; Hinton CV
    J Biol Chem; 2016 May; 291(19):9991-10005. PubMed ID: 26841863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist-induced CXCR4 and CB2 Heterodimerization Inhibits Gα13/RhoA-mediated Migration.
    Scarlett KA; White EZ; Coke CJ; Carter JR; Bryant LK; Hinton CV
    Mol Cancer Res; 2018 Apr; 16(4):728-739. PubMed ID: 29330286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion.
    Nasser MW; Qamri Z; Deol YS; Smith D; Shilo K; Zou X; Ganju RK
    PLoS One; 2011; 6(9):e23901. PubMed ID: 21915267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid receptor CB2 modulates the CXCL12/CXCR4-mediated chemotaxis of T lymphocytes.
    Ghosh S; Preet A; Groopman JE; Ganju RK
    Mol Immunol; 2006 Jul; 43(14):2169-79. PubMed ID: 16503355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-κB activation in breast and pancreatic tumor cells.
    Chua AW; Hay HS; Rajendran P; Shanmugam MK; Li F; Bist P; Koay ES; Lim LH; Kumar AP; Sethi G
    Biochem Pharmacol; 2010 Nov; 80(10):1553-62. PubMed ID: 20699088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.
    Hsiao JJ; Ng BH; Smits MM; Wang J; Jasavala RJ; Martinez HD; Lee J; Alston JJ; Misonou H; Trimmer JS; Wright ME
    BMC Cancer; 2015 Mar; 15():204. PubMed ID: 25884570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone Cell-autonomous Contribution of Type 2 Cannabinoid Receptor to Breast Cancer-induced Osteolysis.
    Sophocleous A; Marino S; Logan JG; Mollat P; Ralston SH; Idris AI
    J Biol Chem; 2015 Sep; 290(36):22049-60. PubMed ID: 26195631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential functional activation of chemokine receptor CXCR4 is mediated by G proteins in breast cancer cells.
    Holland JD; Kochetkova M; Akekawatchai C; Dottore M; Lopez A; McColl SR
    Cancer Res; 2006 Apr; 66(8):4117-24. PubMed ID: 16618732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the 90-kDa heat shock protein (Hsp-90) in CB2 cannabinoid receptor-mediated cell migration: a new role of Hsp-90 in migration signaling of a G protein-coupled receptor.
    He F; Qiao ZH; Cai J; Pierce W; He DC; Song ZH
    Mol Pharmacol; 2007 Nov; 72(5):1289-300. PubMed ID: 17698952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation.
    Melck D; De Petrocellis L; Orlando P; Bisogno T; Laezza C; Bifulco M; Di Marzo V
    Endocrinology; 2000 Jan; 141(1):118-26. PubMed ID: 10614630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells.
    Lee BC; Lee TH; Avraham S; Avraham HK
    Mol Cancer Res; 2004 Jun; 2(6):327-38. PubMed ID: 15235108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis.
    Mochizuki H; Matsubara A; Teishima J; Mutaguchi K; Yasumoto H; Dahiya R; Usui T; Kamiya K
    Biochem Biophys Res Commun; 2004 Jul; 320(3):656-63. PubMed ID: 15240098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting CB2-GPR55 receptor heteromers modulates cancer cell signaling.
    Moreno E; Andradas C; Medrano M; Caffarel MM; Pérez-Gómez E; Blasco-Benito S; Gómez-Cañas M; Pazos MR; Irving AJ; Lluís C; Canela EI; Fernández-Ruiz J; Guzmán M; McCormick PJ; Sánchez C
    J Biol Chem; 2014 Aug; 289(32):21960-72. PubMed ID: 24942731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cysteine (C)-x-C receptor 4 undergoes transportin 1-dependent nuclear localization and remains functional at the nucleus of metastatic prostate cancer cells.
    Don-Salu-Hewage AS; Chan SY; McAndrews KM; Chetram MA; Dawson MR; Bethea DA; Hinton CV
    PLoS One; 2013; 8(2):e57194. PubMed ID: 23468933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G protein-coupled receptor crosstalk and signaling in hematopoietic stem and progenitor cells.
    Möhle R; Drost AC
    Ann N Y Acad Sci; 2012 Aug; 1266():63-7. PubMed ID: 22901257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activation.
    Ziarek JJ; Kleist AB; London N; Raveh B; Montpas N; Bonneterre J; St-Onge G; DiCosmo-Ponticello CJ; Koplinski CA; Roy I; Stephens B; Thelen S; Veldkamp CT; Coffman FD; Cohen MC; Dwinell MB; Thelen M; Peterson FC; Heveker N; Volkman BF
    Sci Signal; 2017 Mar; 10(471):. PubMed ID: 28325822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.
    Wu M; Chen Q; Li D; Li X; Li X; Huang C; Tang Y; Zhou Y; Wang D; Tang K; Cao L; Shen S; Li G
    J Cell Biochem; 2008 Jan; 103(1):245-55. PubMed ID: 17549698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emodin inhibits invasion and migration of prostate and lung cancer cells by downregulating the expression of chemokine receptor CXCR4.
    Ok S; Kim SM; Kim C; Nam D; Shim BS; Kim SH; Ahn KS; Choi SH; Ahn KS
    Immunopharmacol Immunotoxicol; 2012 Oct; 34(5):768-78. PubMed ID: 22299827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic Analysis of the Early Signaling Steps of the Human Chemokine Receptor CXCR4.
    Perpiñá-Viciano C; Işbilir A; Zarca A; Caspar B; Kilpatrick LE; Hill SJ; Smit MJ; Lohse MJ; Hoffmann C
    Mol Pharmacol; 2020 Aug; 98(2):72-87. PubMed ID: 32474443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.